TJP1 and breast cancer: In line with this epithelial divergence, previous studies have described that BT474 cells generally maintain higher expression of epithelial junctional markers, such as β-catenin and ZO-1, and lower EMT-associated regulator levels compared with more adhesion-impaired breast cancer models.